Refinement

Joanne Zurlo, Eric Hutchinson

3-10

Pathways of Toxicity

Andre Kleensang, Alexandra Maertens, Michael Rosenberg, Suzanne Fitzpatrick, Justin Lamb, Scott Auerbach, Richard Brennan, Kevin M. Crofton, Ben Gordon, Albert J. Jr. Fornace, Kevin Gaido, David Gerhold, Robin Haw, Adriano Henney, Avi Ma’ayan, Mary McBride, Stefano Monti, Michael F. Ochs, Akhilesh Pandey, Roded Sharan, Rob Stierum, Stuart Tugendreich, Catherine Willett, Clemens Wittwehr, Jianguo Xia, Geoffrey W. Patton, Kirk Arvidson, Mounir Bouhifd, Helena T. Hogberg, Thomas Luechtefeld, Lena Smirnova, Liang Zhao, Yeyejide Adeleye, Minoru Kanehisa, Paul Carmichael, Melvin E. Andersen, Thomas Hartung

53-61

Lessons learned, challenges, and opportunities: The U.S. Endocrine Disruptor Screening Program

Daland R. Juberg, Susan J. Borghoff, Richard A. Becker, Warren Casey, Thomas Hartung, Michael P. Holsapple, M. Sue Marty, Ellen M. Mihaich, Glen Van Der Kraak, Michael G. Wade, Catherine E. Willett, Melvin E. Andersen, Christopher J. Borgert, Katherine K. Coady, Michael L. Dourson, John R. Fowle III, L. Earl Gray, James C. Lamb, Lisa S. Ortego, Thaddeus T. Schug, Colleen M. Toole, Leah M. Zorrilla, Oliver L. Kroner, Jacqueline Patterson, Lori A. Rinckel, Brett R. Jones

63-78

A computational approach to mechanistic and predictive toxicology of pesticides

Kristine Kongsbak, Anne Marie Vinggaard, Niels Hadrup, Karine Audouze

11-22

An alternative QSAR-based approach for predicting the bioconcentration factor for regulatory purposes

Andrea Gissi, Domenico Gadaleta, Matteo Floris, Stefania Olla, Angelo Carotti, Ettore Novellino, Emilio Benfenati, Orazio Nicolotti

23-36

Highly sensitive detection of cancer antigen 15-3 using novel avian IgY antibodies

Renata Grzywa, Agnieszka Łupicka-Słowik, Maciej Walczak, Magdalena Idzi, Kamila Bobrek, Stephane Boivin, Andrzej Gaweł, Tadeusz Stefaniak, Józef Oleksyszyn, Marcin Sieńczyk

43-52

Toxicology and stem cells: New frontiers

Francesca Caloni, Maura Ferrari, Isabella De Angelis

94

Correlating in vitro data to in vivo findings for risk assessment

Ambuja S. Bale, Elaina Kenyon, Thomas J. Flynn, John C. Lipscomb, Donna L. Mendrick, Thomas Hartung, Geoffrey W. Patton

79-90